CORTESI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 20.092
AS - Asia 10.885
EU - Europa 7.390
SA - Sud America 1.726
Continente sconosciuto - Info sul continente non disponibili 411
AF - Africa 215
OC - Oceania 16
Totale 40.735
Nazione #
US - Stati Uniti d'America 19.624
SG - Singapore 4.138
CN - Cina 2.587
FI - Finlandia 2.205
IT - Italia 1.389
BR - Brasile 1.349
VN - Vietnam 1.107
UA - Ucraina 983
HK - Hong Kong 876
DE - Germania 724
GB - Regno Unito 619
TR - Turchia 526
FR - Francia 344
IN - India 320
JP - Giappone 314
BD - Bangladesh 313
SE - Svezia 283
RU - Federazione Russa 250
CA - Canada 203
PL - Polonia 174
MX - Messico 170
ID - Indonesia 139
AR - Argentina 128
IQ - Iraq 107
NL - Olanda 79
ZA - Sudafrica 78
CO - Colombia 70
PK - Pakistan 60
AT - Austria 59
EC - Ecuador 56
ES - Italia 49
TH - Thailandia 41
LT - Lituania 39
PH - Filippine 37
BE - Belgio 36
KR - Corea 35
SA - Arabia Saudita 35
CL - Cile 34
VE - Venezuela 34
MY - Malesia 27
RO - Romania 26
IL - Israele 24
NP - Nepal 24
UZ - Uzbekistan 23
IR - Iran 21
JO - Giordania 21
MA - Marocco 20
DZ - Algeria 19
EG - Egitto 19
AE - Emirati Arabi Uniti 18
CH - Svizzera 18
PY - Paraguay 18
CR - Costa Rica 16
JM - Giamaica 16
KE - Kenya 16
CZ - Repubblica Ceca 15
PE - Perù 15
TN - Tunisia 14
PT - Portogallo 13
AU - Australia 12
ET - Etiopia 12
KW - Kuwait 12
UY - Uruguay 12
AL - Albania 11
AZ - Azerbaigian 11
GT - Guatemala 11
KZ - Kazakistan 11
IE - Irlanda 10
LV - Lettonia 10
BO - Bolivia 9
DK - Danimarca 9
HN - Honduras 9
NG - Nigeria 9
TW - Taiwan 9
DO - Repubblica Dominicana 8
MD - Moldavia 8
BF - Burkina Faso 7
GR - Grecia 7
NI - Nicaragua 7
OM - Oman 7
KG - Kirghizistan 6
PA - Panama 6
AO - Angola 5
BG - Bulgaria 5
HU - Ungheria 5
PS - Palestinian Territory 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BB - Barbados 4
BH - Bahrain 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
HR - Croazia 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
LB - Libano 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
Totale 40.284
Città #
Singapore 2.516
Ashburn 2.340
Helsinki 1.968
Woodbridge 1.701
Fairfield 1.647
Houston 1.269
San Jose 1.194
Jacksonville 1.071
Santa Clara 982
Chandler 897
Hong Kong 846
Beijing 825
Ann Arbor 691
Seattle 660
Wilmington 607
Cambridge 576
Ho Chi Minh City 399
Izmir 343
Ferrara 332
Los Angeles 301
New York 297
Council Bluffs 292
Tokyo 288
Nanjing 287
Dallas 265
Princeton 248
Hanoi 247
Lauterbourg 207
Boardman 185
Warsaw 155
São Paulo 134
San Diego 130
Munich 116
Milan 114
Mexico City 107
Shanghai 105
Shenyang 89
Nanchang 84
Buffalo 77
Chicago 77
Jakarta 76
London 76
Hefei 72
Montreal 71
Dearborn 70
Brooklyn 64
Orem 64
Chennai 63
Toronto 63
Bologna 62
Jiaxing 60
Hebei 58
Changsha 56
Rome 54
Da Nang 52
Frankfurt am Main 52
Redwood City 51
Tianjin 50
Boston 48
Moscow 46
Rio de Janeiro 46
Baghdad 44
Haiphong 44
San Francisco 43
Atlanta 42
Denver 42
Vienna 42
Johannesburg 41
Stockholm 38
Manchester 37
The Dalles 37
Turku 36
Falkenstein 35
Phoenix 35
Poplar 34
Belo Horizonte 33
Brussels 33
Jinan 33
Norwalk 33
Mumbai 32
San Mateo 32
Mountain View 31
Ningbo 29
Falls Church 28
Addison 27
Guangzhou 27
Amsterdam 26
Ankara 26
Naples 26
New Delhi 24
Zhengzhou 23
Charlotte 22
Indiana 22
Orange 22
Verona 22
Bengaluru 21
Columbus 21
Curitiba 21
Kunming 21
Tashkent 21
Totale 27.129
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.971
Structural studies of lipid based nanosystems for drug delivery: X-Ray Diffraction (XRD) and Cryogenic Transmission Electron Microscopy (cryo-TEM) 413
Biodistribution of nanostructured lipid carriers: a tomographic study 337
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 306
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 296
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 257
Aminated polysaccharide microspheres as DNA delivery systems 255
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 249
Skin care: The innovative nanotechnology to improve the performance of delivery systems 247
Analysis of the drug release profiles from formulations based on micro and nano systems 243
Cationic lipid nanosystems as carriers for nucleic acids 238
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies 238
Cationic lipospheres as delivery systems for nucleic acid molecules 237
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 234
Acyclovir delivery systems 234
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 231
Amphiphilic association systems for amphotericin B delivery 230
Design and characterization of ethosomes for transdermal delivery of caffeic acid 228
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 227
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 223
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 222
Clotrimazole Nanoparticle gel for mucosal administration. 221
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 220
Progesterone lipid nanoparticles: Scaling up and in vivo human study 220
Data on scaling up and in vivo human study of progesterone lipid nanoparticles 220
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 220
Amphiphilic association systems for Amphotericin B delivery 218
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 216
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 214
Production of lipospheres as carriers for bioactive compounds 211
Monoolein Aqueous Dispersions as a delivery system for quercetin 211
Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation 211
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 211
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 210
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 209
L-dopa co-drugs in nanostructured lipid carriers: a comparative study 208
Ethosomes and organogels for cutaneous administration of crocin 207
Budesonide microparticles for the treatment of Crohn's disease 205
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior 205
Liposomes as carriers for DNA-PNA hybrids 203
Investigation of the bioequivalence of Rosuvastatin 20 mg tablets after a single oral administration in mediterranean arabs using a validated LC MS/MS method 203
"Plurethosome" as vesicular system for cutaneous administration of mangiferin: formulative study and 3D skin tissue evaluation 203
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 202
Design and characterization of fenretinide containing organogels 202
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 201
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 201
Challenges in the physical characterization of lipid nanoparticles 201
Microparticles as delivery systems for local delivery to the oral cavity. 200
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 200
Encapsulation of cannabinoid drugs in nanostructured lipid carriers 200
Cationic lipid nanosystems as carriers for nucleic acids 200
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 199
Gelified reverse micellar dispersions as percutaneous formulations 198
Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.) 198
Gallic acid loaded poloxamer gel as new adjuvant strategy for melanoma: A preliminary study 197
Influence of formulation and process parameters on pellet production by powder layering technique 196
Nanosistemi lipidici per la veicolazione di acidi nucleici 196
Microparticles containing gallic and ellagic acids for the biological control of bacterial diseases of kiwifruit plants 196
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 196
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 195
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles 195
Preparation of high-solid PLA waterborne dispersions with PEG-PLA-PEG block copolymer as surfactant and their use as hydrophobic coating on paper 189
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 189
Polymeric microparticles for fenretinide administration 189
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 186
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 186
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 186
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 185
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 185
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 185
Eudragit® microparticles for the release of budesonide: A comparative study 184
Bilosomes and Biloparticles for the Delivery of Lipophilic Drugs: A Preliminary Study 183
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 183
Nanosystems for skin hydration: a comparative study 182
Ethosomes and transethosomes for mangiferin transdermal delivery 182
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs 181
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 180
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 180
Curcumin containing monoolein aqueous dispersions: a preformulative study 180
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 179
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 178
Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties 177
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 177
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 176
Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes 174
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 174
Cationic phosphines for the obtaining of non-viral vectors 173
Lipid-based supramolecular systems for topical application: A preformulatory study 173
The potential of caffeic acid lipid nanoparticulate systems for skin application: in vitro assays to assess delivery and antioxidant effect 173
In vitro effect on human leukemic K562 cells of co-administration of liposome-associated retinoids and cytosine arabinoside (Ara-C) 172
Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappa B transcription factors 172
Properties and applications of liposomes in cosmetics 171
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 171
Pharmaceutical and biotechnological applications of multiple emulsions 170
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 170
Formulation and Bioequivalence of Two Valsartan Tablets After a Single Oral Administration 168
Production, physico-chemical characterization and biodistribution studies of lipid nanoparticles 168
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 168
Production of lipospheres for bioactive compounds delivery 167
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 166
Totale 22.267
Categoria #
all - tutte 181.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.095
Totale 190.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.133 0 276 172 123 63 110 122 148 74 208 210 627
2022/20232.222 257 75 69 256 369 376 72 212 293 18 149 76
2023/20241.229 147 150 58 35 91 247 68 67 20 38 54 254
2024/20255.244 157 122 422 163 708 531 131 389 906 482 784 449
2025/202616.425 1.320 692 1.255 1.871 1.876 879 1.632 910 3.232 1.688 660 410
2026/2027796 422 374 0 0 0 0 0 0 0 0 0 0
Totale 40.735